ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat.

Jonathan D Raybuck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.